Ileus in critical illness: Mechanisms and management

Current Opinion in Critical Care

Volumn 8, Issue 2, 2002, Pages 152-157

  Bauer, Anthony J ^a,c   Schwarz, Nicolas T ^b   Moore, Beverley A ^a   Türler, Andreas ^a   Kalff, Jörg C ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALVIMOPAN; CYCLOOXYGENASE 2; NEOSTIGMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OPIATE ANTAGONIST; PROPRANOLOL; PROSTAGLANDIN; UNCLASSIFIED DRUG;

ABDOMINAL SURGERY; BRADYCARDIA; CLINICAL TRIAL; CRITICAL ILLNESS; ENZYME INDUCTION; HUMAN; ILEUS; INFLAMMATION; INFLAMMATORY CELL; INTESTINE MOTILITY; INTESTINE MUSCLE; INTESTINE OBSTRUCTION; MACROPHAGE; MONOCYTE; MORBIDITY; MORTALITY; MOTONEURON; NERVE FUNCTION; NONHUMAN; OGILVIE SYNDROME; POSTOPERATIVE COMPLICATION; PROSTAGLANDIN RELEASE; REVIEW; SEPSIS; SYMPATHETIC FUNCTION;

ENDOTOXINS; HUMANS; INFLAMMATION MEDIATORS; INTESTINAL OBSTRUCTION; MACROPHAGES; NEUROGENIC INFLAMMATION; NITRIC OXIDE; POSTOPERATIVE COMPLICATIONS; SEPSIS;

EID: 0036965933     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-200204000-00011     Document Type: Review

References (87)

1. Cannon WB, Murphy FT: The movement of the stomach and intestine in some surgical conditions. Ann Surg 1906, 43:512-536.
2. Holte K, Kehlet H: Postoperative ileus: a preventable event. Br J Surg 2000, 87:1480-1493. •• An excellent review on the current status of postoperative ileus, covering mechanisms and therapeutic management strategies
3. Bueno L, Ferre JP, Ruckebusch Y: Effects of anesthesia and surgical procedures on intestinal myoelectric activity in rats. Dig Dis 1978, 23:690-695.
4. Livingston EH, Passaro EP Jr: Postoperative ileus. Dig Dis Sci 1990, 35:121-132.
5. Dubois F, Icard P, Berthelot G, et al.: Coelioscopic cholecystectomy: preliminary report of 36 cases. Ann Surg 1990, 211:60-62.
6. Garcia-Caballero M, Vara-Thornbeck C: The evolution of postoperative ileus after laparoscopic cholecystectomy. Surg Endosc 1993, 7:416-419.
7. Ludwig KA, Frantzides CT, Carlson MA, et al.: Myoelectric motility patterns following open versus laparoscopic cholecystectomy. J Laparoendosc Surg 1993, 3:461-466.
8. Schippers E, Ottinger AP, Anurov M, et al.: Laparoscopic cholecystectomy: a minor abdominal trauma? World J Surg 1993, 17:539-543.
9. Böhm B, Milsom JW, Fazio VW: Postoperative intestinal motility following conventional and laparoscopic intestinal surgery. Arch Surg 1995, 130:415-419.
10. Taché Y, Monnikes H, Bonaz B, et al.: Role of CRF in stress-related alterations of gastric and colonic motor function. Ann N Y Acad Sci 1993, 697:233-243.
11. Boeckxstaens GE, Hirsch DP, Kodde A, et al.: Activation of an adrenergic and vagally-mediated NANC pathway in surgery-induced fundic relaxation in the rat. Neurogastroenterol Motil 1999, 11:467-474.
12. De Winter BY, Boeckxstaens GE, De Man JG, et al.: Effect of adrenergic and nitrergic blockade on experimental ileus in rats. Br J Pharmacol 1997, 120:464-468.
13. Boeckxstaens GE, Hollmann M, Heisterkamp SH, et al.: Evidence for VIP(1)/PACAP receptors in the afferent pathway mediating surgery-induced fundic relaxation in the rat. Br J Pharmacol 2000, 131:705-710. •• A continuing series of excellent articles by the Antwerp group investigating the influences of neuronal activation after intestinal manipulation.
14. De Winter BY, Robberecht P, Boeckxstaens GE, et al.: Role of VIP1/PACAP receptors in postoperative ileus in rats. Br J Pharmacol 1998, 124:1181-1186.
15. Reissman P, Agachan F, Wexner SD: Outcome of laparoscopic colorectal surgery in older patients. Am Surg 1996, 62:1060-1063.
16. Kalff JC, Schwarz NT, Walgenbach KJ, et al.: Leukocytes of the intestinal muscularis externa: their phenotype and isolation. J Leukoc Biol 1998, 63:683-691.
17. Bauer AJ: Transplantation-induced injuries to the intestinal muscularis and its innervation: from preservation to chronic rejection. Transplant Proc 1996, 28:2539-2541.
18. Mikkelsen HB: Macrophages in the external muscle layers of mammalian intestines. Histol Histopathol 1995, 10:719-736.
19. Faussone. Pellegrini MS, Pantalone D, Cortesini C: Smooth muscle cells, interstitial cells of Cajal and myenteric plexus interrelationships in the human colon. Acta Anatomica 1990, 139:31-44.
20. Kagan BL, Ganz T, Lehrer RI: Defensins: a family of antimicrobial and cytotoxic peptides. Toxicology 1994, 87:131-149.
21. Cicalese L, Rastellini C, Rao AS, et al.: Pyruvate prevents mucosal reperfusion injury, oxygen free-radical production, and neutrophil infiltration after rat small bowel preservation and transplantation. Transplant Proc 1996, 28:2611.
22. Kalff JC, Schraut WH, Billiar TR, et al.: Roles of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology 1999, 188:316-327. •• Nitric oxide is known to modulate intestinal muscle contractility as an inhibitory neuromuscular transmitter, but in this study, the important kinetic properties of nitric oxide are also demonstrated when it is released from resident and recruited leukocytes from the inducible form of nitric oxide synthase. This study used both pharmacologic and genetically deficient iNOS mice to demonstrate the importance of nitric oxide as induced by intestinal manipulation.
23. Schwarz NT, Kalff JC, Türler A, et al.: Prostanoid production via COX-2 as a causative mechanism of rodent postoperative ileus. Gastroenterology 2001, 121:1354-1371. •• Prostaglandins could be the most potent kinetically active substances on intestinal smooth muscle. The researchers, by using selective cyclooxygenase-2 inhibition with 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulfonyl)phenyl-2(5H)-furanone (DFU) and genetically deficient cyclooxygenase-2 mice, demonstrated an important role for the induction of cyclooxygenase-2 by intestinal manipulation in rodents.
24. Kalff JC, Carlos TM, Schraut WH, et al.: Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology 1999, 117:378-387. • The role of recruited leukocytes in causing prolonged intestinal ileus after surgical manipulation of the intestine is directly demonstrated using adhesion molecular blocking antibodies.
25. Kalff JC, Eskandari MK, Hierholzer C, et al.: Biphasic response to gut manipulation and temporal correlation of cellular infiltrates and muscle dysfunction in rat. Surgery 1999, 126:498-509.
26. 2 increases longitudinal muscle contractility but inhibits circular muscle contractility. Therefore, it is not surprising that in this study using the nematode model, the postinfective activation of cyclooxygenase-2 in resident cells of the muscularis externa contributes to longitudinal muscle hypercontractility.
27. Kalff JC, Schraut WH, Simmons R, et al.: Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postoperative ileus. Ann Surg 1998, 228:652-663.
28. Collins SM, Marzio L, Vermillion DL, et al.: The immunomodulation of gut motility: factors that determine the proliferation of mast cells in the sensitized gut [abstract]. Gastroenterology 1988, 94:A74.
29. Malaviya R, Ross E, Jakschik BA, et al.: Mast cell degranulation induced by Type 1 fimbriated Escherichia coli in mice. J Clin Invest 1994, 93:1645-1653.
30. Coleman JW, Holliday MR, Kimber I, et al.: Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4. J Immunol 1993, 150:556-562.
31. Galli SJ, Gordon JR, Wershil BK: Cytokine production by mast cells and basophils. Curr Opin Immunol 1991, 3:865-873.
32. Wershil BK: Role of mast cells and basophils in gastrointestinal inflammation. Chem Immunol 1995, 62:204-238.
33. Kubes P, Kanwar S: Histamine induces leukocyte rolling in post-capillary venules: a P-selectin-mediated event. J Immunol 1994, 152:3570-3577.
34. Wershil BK, Furuta GT, Wang ZS, et al.: Mast cell-dependent neutrophil and mononuclear cell recruitment in immunoglobulin E-induced gastric reactions in mice. Gastroenterology 1996, 110:1482-1490.
35. Scott RB, Maric M: Mediation of anaphylaxis-induced jejunal circular smooth muscle contraction in rats. Dig Dis Sci 1993, 38:396-402.
36. Schwarz NT, Simmons RL, Bauer AJ: Minor intraabdominal injury followed by low dose LPS administration act synergistically to induce ileus [abstract]. Neurogastroenterol Motil 2000, 11:288.
37. Schwarz NT, Beer-Stolz D, Simmons RL, et al.: Pathogenesis of paralytic ileus: intestinal manipulation opens a transient pathway between the intestinal lumen and the leukocytic infiltrate of the jejunal muscularis. Ann Surg 2002, 235:31-40. •• This study provides a crucial link to studies on translocation and the inflammatory response generated within the muscularis of the manipulated intestine. These data show that intestinal manipulation leads to a transient increase in mucosal permeability and that the extraintestinal endocytotic uptake of transferred particles by circulating monocytes precedes their infiltration into the gut wall. The transference of luminal bacterial products may follow a route and time course similar to that of the microspheres. The researchers hypothesize that endogenous bacterial products act synergistically with the inflammatory response within the postsurgical intestinal muscularis, leading to an exacerbation of postoperative ileus.
38. Collins SM, Hurst SM, Main C, et al.: Effect of inflammation of enteric nerves: cytokine-induced changes in neurotransmitter content and release. Ann N Y Acad Sci 1992, 664:415-424.
39. Galeazzi F, Haapala EM, Van Rooijen N, et al.: Inflammation-induced impairment of enteric nerve function in nematode-infected mice is macrophage dependent. Am J Physiol Gastrointest Liver Physiol 2000, 278:G259-G265. • This study continues the excellent and long-standing series of studies using the nematode model. These data show that depletion of resident muscularis macrophages using liposomes containing the toxin dichloromethylene diphosphonate (clodronate) prevented the infection-induced suppression in acetylcholine release. These data show the involvement of the resident macrophage network in the functional impairment of enteric cholinergic nerves.
40. Kalff JC, Eskandari MK, Hierholzer C, et al.: Selective coinduction of cyclooxygenase-2 and inducible nitric oxide synthase in human intestinal smooth muscle during abdominal surgery [abstract]. Gastroenterology 1998, 114:A774. These data provide evidence that the human surgically manipulated intestinal muscularis responds in a manner similar to that of rodents.
41. Kalff JC, Eskandari MK, Hierholzer C, et al.: IL-6 expression in activated resident muscularis macrophages of the human small intestine after abdominal surgery [abstract]. Gastroenterology 1997, 112:A1159.
42. Ferraz AA, Wanderley GJ, Santos MA Jr, et al.: Effects of propranolol on human postoperative ileus. Dig Surg 2001, 18:305-310. • An important study in humans showing that β-adrenergic blockade is not effective in treating postoperative ileus.
43. De Winter BY, Boeckxstaens GE, De Man JG, et al.: Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats. Gut 1999, 45:713-718.
44. Bungard TJ, Kale-Pradhan PB: Prokinetic agents for the treatment of postoperative ileus in adults: a review of the literature. Pharmacotherapy 1999, 19:416-423.
45. Seta ML, Kale-Pradhan PB: Efficacy of metoclopramide in postoperative ileus after exploratory laparotomy. Pharmacotherapy 2001, 21:1181-1186.
46. Trevisani GT, Hyman NH, Church JM: Neostigmine: safe and effective treatment for acute colonic pseudo-obstruction. Dis Colon Rectum 2000, 43:599-603.
47. Kreis ME, Kasparek M, Zittel TT, et al.: Neostigmine increases postoperative colonic motility in patients undergoing colorectal surgery. Surgery 2001, 130:449-456. • Neostigmine, through its antiacetylcholinesterase properties, stimulates colonic contractions, possibly affording temporary symptomatic relief from postoperative ileus.
48. Althausen PL, Gupta MC, Benson DR, et al.: The use of neostigmine to treat postoperative ileus in orthopedic spinal patients. J Spinal Disord 2001, 14:541-545.
49. Isbister GK, Oakley P, Whyte I, et al.: Treatment of anticholinergic-induced ileus with neostigmine. Ann Emerg Med 2001, 38:689-693.
50. van der Spoel JI, Oudemans-van Straaten HM, Stoutenbeek CP, et al.: Neostigmine resolves critically illness-related colonic ileus in intensive care patients with multiple organ failure: a prospective, double-blind, placebo-controlled trial. Intensive Care Med 2001, 27:822-827.
51. De Winter BY, Boeckxstaens GE, De Man JG, et al.: Effects of mu- and kappa-opioid receptors on postoperative ileus in rats. Eur J Pharmacol 1997, 339:63-67.
52. Taguchi A, Sharma N, Saleem RM, et al.: Selective postoperative inhibition of gastrointestinal opioid receptors. N Engl J Med 2001, 345:935-940. •• Opioids are known to decrease inhibitory neuromuscular transmission. Adolor (Extort, PA) has designed an opioid antagonist to offset the untoward gastrointestinal effects of endogenously released and therapeutic opioids for postsurgical pain.
53. Liu SS, Hodgson PS, Carpenter RL, et al.: ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia. Clin Pharmacol Ther 2001, 69:66-71.
54. Basse L, Madsen J, Kehlet H: Normal gastrointestinal transit after colonic resection using epidural analgesia, enforced oral nutrition and laxative. Br J Surg 2001, 88:1498-1500. •• This group has shown that aggressive postsurgical treatment of the patient with combinatorial therapy is effective in reducing time to defecation after surgery.
55. Anning PB, Evans TW: Leukocytes in sepsis: do they just keep rolling along? [editorial]. Crit Care Med 2000, 28:3108-3109.
56. Deitch EA, Rutan R, Waymack JP: Trauma, shock, and gut translocation. New Horiz 1996, 4:289-299.
57. O'Boyle CJ, MacFie J, Mitchell CJ, et al.: Microbiology of bacterial translocation in humans. Gut 1998, 42:29-35.
58. O'Dwyer ST, Michie HR, Ziegler TR, et al.: A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg 1988, 123:1459-1464.
59. Hutcheson IR, Whittle BJ, Boughton-Smith NK: Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990, 101:815-820.
60. Moore FA: The role of the gastrointestinal tract in postinjury multiple organ failure. Am J Surg 1999, 178:449-453. •• A good review on the role of the gastrointestinal tract in multiple organ failure.
61. Fink MP: Does tissue acidosis in sepsis indicate tissue hypoperfusion? Intensive Care Med 1996, 22:1144-1146.
62. Eskandari MK, Kalff JC, Billiar TR, et al.: LPS-induced muscularis macrophage nitric oxide suppresses rat jejunal circular muscle activity. Am J Physiol 1999, 277:G478-G486. •• Macrophages are known to secrete copious amounts of nitric oxide in response to lipopolysaccharide. These data show that the dense network of resident macrophages within the normal muscularis is similar in this regard to other macrophage populations, and that the induction of iNOS and the liberation of nitric oxide have a local inhibitory paracrine effect on the adjacent smooth muscle cells of the muscularis externa.
63. Cullen JJ, Caropreso DK, Ephgrave KS: Effect of endotoxin on canine gastrointestinal motility and transit. J Surg Res 1995, 58:90-95.
64. Cullen JJ, Ephgrave KS, Caropreso DK: Gastrointestinal myoelectric activity during endotoxemia. Am J Surg 1996, 171:596-599.
65. Weisbrodt NW, Pressley TA, Li Y, et al.: Decreased ileal muscle contractility and increased NOS II expression induced by lipopolysaccharide. Am J Physiol 1996, 271:G454-G460.
66. Lodato RF, Khan AR, Zembowicz MJ, et al.: Roles of IL-1 and TNF in the decreased ileal muscle contractility induced by lipopolysaccharide. Am J Physiol Gastrointest Liver Physiol 1999, 276:G1356-G1362. •• TNF and IL-1 are shown to play a role in the induction of iNOS and the subsequent inhibition of smooth muscle contractility.
67. Torihashi S, Ozaki H, Hori M, et al.: Resident macrophages activated by lipopolysaccharide suppress muscle tension and initiate inflammatory response in the gastrointestinal muscle layer. Histochem Cell Biol 2000, 113:73-80.
68. Nathan CF: Secretory products of macrophages. J Clin Invest 1987, 79:319-326.
69. Eskandari MK, Kalff JC, Billiar TR, et al.: Lipopolysaccharide activates the muscularis macrophage network and suppresses circular smooth muscle activity. Am J Physiol 1997, 273:G727-G734.
70. Brieland JK, Flory CM, Jones ML, et al.: Regulation of monocyte chemoattractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1 beta. Am J Respir Cell Mol Biol 1995, 12:104-109.
71. Coletta I, Soldo L, Polentarutti N, et al.: Selective induction of MCP-1 in human mesangial cells by the IL-6/slL- 6R complex. Exp Nephrol 2000, 8:37-43.
72. Fuentes ME, Durham SK, Swerdel MR, et al.: Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 1995, 155:5769-5776.
73. Leonard EJ, Yoshimura T: Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 1990, 11:97-101.
74. Villa P, Sartor G, Angelini M, et al.: Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin. Clin Diagn Lab Immunol 1995, 2:549-553.
75. Türler A, Schwarz NT, Türler E, et al.: MCP-1 causes leukocyte recruitment and subsequently endotoxemic ileus in rat. Am J Physiol Gastrointest Liver Physiol 2001, 282:G145-G155. •• The chemokine MCP-1, produced from the resident muscularis macrophage, is shown to play a role mechanistically in the recruitment of monocytes into the intestinal muscularis. The recruited leukocytes then inhibit muscle contractility by the secretion of kinetically active substances such as nitric oxide and prostaglandins.
76. Zisman DA, Kunkel SL, Strieter RM, et al.: MCP-1 protects mice in lethal endotoxemia. J ClinInvest 1997, 99:2832-2836.
77. Matsukawa A, Hogaboam CM, Lukacs NW, et al.: Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis. Exp Mol Pathol 2000, 68:77-84.
78. Zisman DA, Kunkel SL, Strieter RM, et al.: MCP-1 protects mice in lethal endotoxemia. J Clin Invest 1997, 99:2832-2836.
79. Matsukawa A, Hogaboam CM, Lukacs NW, et al.: Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. J Immunol 1999, 163:6148-6154.
80. Eskandari MK, Kalff JC, Billiar TR, et al.: Lipopolysaccharide activates the muscularis macrophage network and suppresses circular smooth muscle activity. Am J Physiol 1997, 273:G727-G734.
81. Eskandari MK, Kalff JC, Billiar TR, et al.: LPS-induced muscularis macrophage nitric oxide suppresses rat jejunal circular muscle activity. Am J Physiol 1999, 277:G478-G486.
82. Torihashi S, Ozaki H, Hori M, et al.: Resident macrophages activated by lipopolysaccharide suppress muscle tension and initiate inflammatory response in the gastrointestinal muscle layer. Histochem Cell Biol 2000, 113:73-80.
83. Granger DN: Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 1988, 255:H1269-H1275.
84. Mehta JL, Lawson DL, Nicolini FA, et al.: Effects of activated polymorphonuclear leukocytes on vascular smooth muscle tone. Am J Physiol 1991, 261:H327-H334.
85. Botella A, Delvaux M, Fioramonti J, et al.: Stimulatory (EP1 and EP3) and inhibitory (EP2) prostaglandin E2 receptors in isolated ileal smooth muscle cells. Eur J Pharmacol 1993, 237:131-137.
86. Sanders KM: Endogenous prostaglandin E and contractile activity of isolated ileal smooth muscle. Am J Physiol 1978, 234:E209-E212.
87. Hori M, Kita M, Torihashi S, et al.: Upregulation of iNOS by COX-2 in muscularis resident macrophage of rat intestine stimulated with LPS. Am J Physiol Gastrointest Liver Physiol 2001, 280:G930-G938. •• This study finds that lipopolysaccharide increases iNOS and cyclooxygenase-2 expression and stimulates nitric oxide and prostaglandin production in muscularis resident macrophages, resulting in the inhibition of intestinal smooth muscle contraction. Furthermore, their data suggest that lipopolysaccharide-induced iNOS. gene expression may be modulated by the local upregulation of the cyclooxygenase-2 gene and prostaglandin release.